StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$33.39−0.68 (-2.00%)

Close on Nov 19, 2026Market cap $2.20BP/E 6.2Yield –

Lakefront Biotherapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was €295.04M. The highest annual figure on record is €368.75M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025€295.04M–
FY2024Dec 31, 2024-€188.34M–
FY2023Dec 31, 2023-€88.26M–
FY2022Dec 31, 2022-€131.06M–
FY2021Dec 31, 2021-€171.57M–
FY2020Dec 31, 2020-€178.63M-148.4%
FY2019Dec 31, 2019€368.75M–
FY2018Dec 31, 2018-€47.08M–
FY2017Dec 31, 2017-€89.80M–
FY2016Dec 31, 2016-€11.49M–
FY2015Dec 31, 2015-€89.44M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2021Jun 30, 2021-€46.75M–
Q2 FY2020Jun 30, 2020-€88.17M–
Q2 FY2019Jun 30, 2019-€44.37M–
Q2 FY2018Jun 30, 2018-€33.75M–
Q2 FY2017Jun 30, 2017-€21.68M–

More Lakefront Biotherapeutics figures

See a number that looks wrong?